Literature DB >> 31179295

Genetics and epigenetic factors of Wilson disease.

Valentina Medici1, Janine M LaSalle2.   

Abstract

Wilson disease (WD) is a complex condition due to copper accumulation mainly in the liver and brain. The genetic base of WD is represented by pathogenic mutations of the copper-transporting gene ATP7B with consequent lack of copper excretion through the biliary tract. ATP7B is the only gene so far identified and known to be responsible for the development of the disease. Our understanding of the disease has been evolving as functional studies have associated specific disease-causing mutations with specific copper-transporter impairments. The most frequent variant in patients of European descent is the H1069Q missense mutation and it has been associated with protein misfolding, aberrant phosphorylation of the P-domain, and altered ATP binding orientation and affinity. Conversely, there is much less understanding of the relation between the genotype and the clinical manifestations of WD. WD is characterized by a highly varied and unpredictable presentation with different combined hepatic, neurological, and psychiatric symptoms. Several studies have attempted to correlate genotype and phenotype but the most recent evidences on larger populations failed to identify a relation between genotype and clinical presentations. Given that so far also modifier genes have not shown convincing association with WD, there is growing interest to identify epigenetic mechanisms of gene expression regulation as underlying the onset and progression of WD phenotype. Evidence from animal models indicated changes in methionine metabolism regulation with possible effects on DNA methylation. Mouse models of WD have indicated transcript level changes of genes related to DNA methylation in fetal and adult livers. And finally, evidence is accumulating regarding DNA methylation changes in patients with WD. It is unexplored how ATP7B genetic mutations combine with epigenetic changes to affect the phenotype. In conclusion, WD is a genetic disease with a complex regulation of its phenotype that includes molecular genetics and epigenetic mechanisms.

Entities:  

Keywords:  Copper; gene; methylation

Year:  2019        PMID: 31179295      PMCID: PMC6531661          DOI: 10.21037/atm.2019.01.67

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  112 in total

1.  Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease.

Authors:  T Okada; Y Shiono; H Hayashi; H Satoh; T Sawada; A Suzuki; Y Takeda; M Yano; K Michitaka; M Onji; H Mabuchi
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease.

Authors:  M Schiefermeier; H Kollegger; C Madl; C Polli; W Oder; H Kühn; F Berr; P Ferenci
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

Review 3.  The Wilson's disease gene and phenotypic diversity.

Authors:  S M Riordan; R Williams
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

4.  High prevalence of the very rare Wilson disease gene mutation Leu708Pro in the Island of Gran Canaria (Canary Islands, Spain): a genetic and clinical study.

Authors:  L García-Villarreal; S Daniels; S H Shaw; D Cotton; M Galvin; J Geskes; P Bauer; A Sierra-Hernández; A Buckler; A Tugores
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

5.  Mutation analysis in patients of Mediterranean descent with Wilson disease: identification of 19 novel mutations.

Authors:  G Loudianos; V Dessi; M Lovicu; A Angius; B Altuntas; R Giacchino; M Marazzi; M Marcellini; M R Sartorelli; G C Sturniolo; N Kocak; A Yuce; N Akar; M Pirastu; A Cao
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

6.  Frequency of His1069Gln and Gly1267Lys mutations in Polish Wilson's disease population.

Authors:  B Tarnacka; G Gromadzka; M Rodo; P Mierzejewski; A Czloonkowska
Journal:  Eur J Neurol       Date:  2000-09       Impact factor: 6.089

7.  High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis.

Authors:  K Caca; P Ferenci; H J Kühn; C Polli; H Willgerodt; B Kunath; W Hermann; J Mössner; F Berr
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

8.  HFE gene mutations and iron metabolism in Wilson's disease.

Authors:  Andreas Erhardt; Arne Hoffmann; Harald Hefter; Dieter Häussinger
Journal:  Liver       Date:  2002-12

9.  Fetal origins of adult disease: strength of effects and biological basis.

Authors:  D J P Barker; J G Eriksson; T Forsén; C Osmond
Journal:  Int J Epidemiol       Date:  2002-12       Impact factor: 7.196

10.  Molecular characterization of wilson disease in the Sardinian population--evidence of a founder effect.

Authors:  G Loudianos; V Dessi; M Lovicu; A Angius; A Figus; F Lilliu; S De Virgiliis; A M Nurchi; A Deplano; P Moi; M Pirastu; A Cao
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

View more
  10 in total

Review 1.  Wilson Disease: Update on Pathophysiology and Treatment.

Authors:  Som Dev; Robert L Kruse; James P Hamilton; Svetlana Lutsenko
Journal:  Front Cell Dev Biol       Date:  2022-05-02

2.  p.P1379S, a benign variant with reduced ATP7B protein level in Wilson Disease.

Authors:  Fan Yi; Sheri A Poskanzer; Candace T Myers; Jenny Thies; Christopher J Collins; Remwilyn Dayuha; Phi Duong; Roderick Houwen; Si Houn Hahn
Journal:  JIMD Rep       Date:  2020-05-19

3.  Wilson disease - the impact of hyperimmunity on disease activity: A case report.

Authors:  Wolfgang Stremmel; Thomas Longerich; René Liere; Vladimir Vacata; Josef van Helden; Ralf Weiskirchen
Journal:  World J Clin Cases       Date:  2021-02-26       Impact factor: 1.337

4.  Altered diversity and composition of gut microbiota in Wilson's disease.

Authors:  Xiangsheng Cai; Lin Deng; Xiaogui Ma; Yusheng Guo; Zhiting Feng; Minqi Liu; Yubin Guan; Yanting Huang; Jianxin Deng; Hongwei Li; Hong Sang; Fang Liu; Xiaorong Yang
Journal:  Sci Rep       Date:  2020-12-11       Impact factor: 4.379

5.  Systemic deletion of Atp7b modifies the hepatocytes' response to copper overload in the mouse models of Wilson disease.

Authors:  Abigael Muchenditsi; C Conover Talbot; Aline Gottlieb; Haojun Yang; Byunghak Kang; Tatiana Boronina; Robert Cole; Li Wang; Som Dev; James P Hamilton; Svetlana Lutsenko
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

6.  Estimating the clinical prevalence of Wilson's disease in the UK.

Authors:  Pramudi Wijayasiri; Jatinder Hayre; Edward S Nicholson; Philip Kaye; Emilie A Wilkes; Jonathan Evans; Guruprasad P Aithal; Gabriela Jones; Fiona Pearce; Aloysious D Aravinthan
Journal:  JHEP Rep       Date:  2021-07-07

7.  Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease.

Authors:  Mingming Li; Jing Ma; Wenlong Wang; Xu Yang; Kaizhong Luo
Journal:  BMC Gastroenterol       Date:  2021-09-01       Impact factor: 3.067

Review 8.  Wilson disease and the differential diagnosis of its hepatic manifestations: a narrative review of clinical, laboratory, and liver histological features.

Authors:  Shannon M Schroeder; Karen E Matsukuma; Valentina Medici
Journal:  Ann Transl Med       Date:  2021-09

Review 9.  Epigenetics in inflammatory liver diseases: A clinical perspective (Review).

Authors:  Teodora Isac; Sebastian Isac; Razvan Rababoc; Mihail Cotorogea; Laura Iliescu
Journal:  Exp Ther Med       Date:  2022-04-04       Impact factor: 2.751

10.  Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series.

Authors:  Oriol De Fabregues; Jaume Viñas; Antoni Palasí; Manuel Quintana; Ignasi Cardona; Cristina Auger; Víctor Vargas
Journal:  Brain Behav       Date:  2020-03-22       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.